James Nuttall
Overview
Explore the profile of James Nuttall including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
46
Citations
631
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Craig J, Frost I, Sriram A, Nuttall J, Kapoor G, Alimi Y, et al.
J Public Health Afr
. 2022 Feb;
12(2):2009.
PMID: 35126891
Standard treatment guidelines (STGs) are an important tool for ensuring high quality clinical care and prudent antimicrobial use (AMU) and stewardship (AMS). In 2018, African Union (AU) member state representatives...
12.
Levin L, Horak J, Nuttall J
South Afr J HIV Med
. 2021 Oct;
22(1):1283.
PMID: 34691770
Antiretroviral treatment has undergone major changes in the last 20 years, from monotherapy, to dual therapy and finally to triple therapy. Lately, more focus has been placed on better, more...
13.
Ogunbosi B, Moodley C, Naicker P, Nuttall J, Bamford C, Eley B
PLoS One
. 2020 Nov;
15(11):e0241776.
PMID: 33156820
Introduction: There are few studies describing colonisation with extended spectrum beta-lactamase-producing Enterobacterales (ESBL-PE) and carbapenem-resistant Enterobacterales (CRE) among children in sub-Saharan Africa. Colonisation often precedes infection and multi-drug-resistant Enterobacterales are...
14.
Dame J, Beylis N, Nuttall J, Eley B
BMC Infect Dis
. 2020 Oct;
20(1):729.
PMID: 33028225
Background: This study describes the disease burden, clinical characteristics, antibiotic management, impact of multidrug resistance and outcome of Pseudomonas aeruginosa bloodstream infection (PABSI) among children admitted to a tertiary referral...
15.
Enimil A, Eley B, Nuttall J
South Afr J HIV Med
. 2020 Sep;
21(1):1121.
PMID: 32934837
Introduction: There is very limited published experience with intravenous (IV) antituberculosis (anti-TB) and antiretroviral therapy (ART) especially in children. We have described a human immunodeficiency virus (HIV)-infected child with complicated...
16.
Wessels J, Sherman G, Bamford L, Makua M, Ntloana M, Nuttall J, et al.
South Afr J HIV Med
. 2020 Aug;
21(1):1079.
PMID: 32832113
No abstract available.
17.
Adamson H, Nicholl A, Tiede C, Tang A, Davidson A, Curd H, et al.
Biotechniques
. 2019 Dec;
67(6):261-269.
PMID: 31823668
Therapeutic antibodies are the fastest growing class of drugs in the treatment of cancer, and autoimmune and inflammatory diseases that require the concomitant development of assays to monitor therapeutic antibody...
18.
Malande O, Nuttall J, Pillay V, Bamford C, Eley B
PLoS One
. 2019 Sep;
14(9):e0222675.
PMID: 31550295
Introduction: There are few studies describing Escherichia coli (E. coli) bloodstream infection (BSI) among children in Africa, yet E.coli is increasing in importance as a cause of antibiotic resistant infection...
19.
Meintjes G, Brust J, Nuttall J, Maartens G
Lancet HIV
. 2019 Jul;
6(7):e463-e474.
PMID: 31272663
Every year, about 1 million people living with HIV worldwide develop tuberculosis. Although the drug regimens used to treat tuberculosis in these patients are the same as those used in...
20.
Patten G, Schomaker M, Davies M, Rabie H, van Zyl G, Technau K, et al.
Pediatr Infect Dis J
. 2019 Mar;
38(4):400-405.
PMID: 30882732
Background: Managing virologic failure (VF) in HIV-infected children is especially difficult in resource-limited settings, given limited availability of alternative drugs, concerns around adherence, and the development of HIV resistance mutations....